CDEK
← All organizations

SkyePharma AG

For profitWebsite ↗

Also known as: Skye Biologics | Skye Biologics, Inc. | Skye Bioscience, Inc. | SKYEPHARMA AG

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Oct 1, 2004

First marketed drug

Oct 7, 1999

Last known activity

Aug 22, 2024

Timeline

1980s

  1. Jan 1, 1983

    SkyePharma AG— Founded

1990s

  1. Oct 7, 1999

    isosorbide— Marketing Organization

2000s

  1. May 7, 2005

    fenofibrate— NDA Secondary Org

2020s

  1. Nov 11, 2022

    Emerald Health Pharmaceuticals— Acquired

  2. Aug 21, 2023

    Bird Rock Bio, Inc.— Acquired

Drugs by trial phase (13 distinct, 18 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (1 own, 2 via acquisition)

Indications

Studied for

Marketed drugs (2)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (15)

Details

Founded
Saint-Quentin-Fallavier, FR Jan 1, 1983
Last known activity
Aug 22, 2024